↓ Skip to main content

Erythropoietin in Acute Kidney Injury (EAKI): a pragmatic randomized clinical trial

Overview of attention for article published in BMC Nephrology, March 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

blogs
2 blogs
twitter
46 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Erythropoietin in Acute Kidney Injury (EAKI): a pragmatic randomized clinical trial
Published in
BMC Nephrology, March 2022
DOI 10.1186/s12882-022-02727-5
Pubmed ID
Authors

Mabel Aoun, Ghassan Sleilaty, Celine Boueri, Eliane Younes, Kim Gabriel, Reine-Marie Kahwaji, Najla Hilal, Jenny Hawi, Rita Araman, Dania Chelala, Chadia Beaini

X Demographics

X Demographics

The data shown below were collected from the profiles of 46 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 3 10%
Student > Bachelor 3 10%
Student > Postgraduate 3 10%
Student > Master 2 6%
Student > Ph. D. Student 1 3%
Other 2 6%
Unknown 17 55%
Readers by discipline Count As %
Medicine and Dentistry 5 16%
Nursing and Health Professions 2 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Environmental Science 1 3%
Earth and Planetary Sciences 1 3%
Other 3 10%
Unknown 18 58%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 38. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 March 2024.
All research outputs
#1,096,143
of 25,753,031 outputs
Outputs from BMC Nephrology
#55
of 2,789 outputs
Outputs of similar age
#27,051
of 451,435 outputs
Outputs of similar age from BMC Nephrology
#3
of 70 outputs
Altmetric has tracked 25,753,031 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,789 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 451,435 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.